Health
Antibodies from COVID-19 infection protect patients for six months – Drug Target Review
A study in healthcare workers has shown that antibodies from COVID-19 infection protect individuals for at least six months.
Posted: 24 November 2020 | Victoria Rees (Drug Target Review) | No comments yet
A study in healthcare workers has shown that antibodies from COVID-19 infection protect individuals from reinfection for at least six months.
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again for at least six months following their first infection. The study was conducted as part of a collaboration between the University of Oxford and Oxford University…
-
Noosa News18 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General19 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business24 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock
-
General24 hours agoStocks, dollar sink as trade war roils markets